IP Library Granted Patent US 7,179,895
Granted Patent B2
US 7,179,895 · App. 10/924,081 · Granted Feb 20, 2007

Rat calcium channel subunits and related probes, cell lines and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,179,895
App. No.
10/924,081
Granted
Feb 20, 2007
Kind
B2
Abstract

Novel sequences for calcium channel α 2 δ-2 and α 2 δ-3 subunits are provided. Also provided are cell lines that express the novel calcium channel subunits of the invention. These cells may be used for identifying compounds capable of stimulating or inhibiting the activation of the calcium channels.

Claims (10)

1. An isolated nucleic acid comprising a nucleotide sequence that encodes a calcium channel subunit having the amino acid sequence of SEQ ID NO: 3 or a fragment thereof which encodes a functional α 2 δ-2 subunit, wherein the fragment is a truncated form of SEQ ID NO: 3, wherein the truncation involves removing up to 20 amino acids from the α 2 and/or δ portions.

2. A recombinant nucleic acid molecule which comprises a nucleotide sequence as set forth in claim 1 , operably linked to control sequences to effect its expression.

3. The nucleic acid of claim 2 , wherein said control sequences are operable in vertebrate cells.

4. Recombinant host cells which contain the nucleic acid molecule of claim 2 .

5. Vertebrate host cells which contain the nucleic acid molecule of claim 3 .

6. The vertebrate host cells of claim 5 , wherein said cells further comprise an expression vector which comprises an expression control sequence operably linked to a nucleotide sequence which encodes an α 1 calcium channel subunit.

7. A method to prepare cells that display functional calcium ion channel, which method comprises culturing cells which display an α 1 subunit and which further comprise the nucleic acid molecule of claim 2 .

8. Recombinant cells prepared by the method of claim 7 .

9. The isolated nucleic acid of claim 1 wherein 10–15 of the up to 20 amino acids are removed.

10. The isolated nucleic acid of claim 1 which encodes SEQ ID NO:3.

Assignments (4)
CHANGE OF NAME Recorded Sep 15, 2010
From: NEUROMED PHARMACEUTICALS LTD.
To: ZALICUS PHARMACEUTICALS LTD.
Reel/Frame 024990/0430 →
CHANGE OF NAME Recorded Aug 11, 2006
From: NEUROMED TECHNOLOGIES INC.
To: NEUROMED PHARMACEUTICALS LTD.
Reel/Frame 018099/0664 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2005
From: PARKER, DAVID; XU, XIANGHONG; KHAWAJA, AFSHEEN; SNUTCH, TERRANCE P.
To: NEUROMED TECHNOLOGIES INC.
Reel/Frame 015531/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2004
From: PETERSON, SHEP; DAVIS, ROBERT P.
To: TUMI, INC.
Reel/Frame 015979/0821 →